Cargando…
The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome
BACKGROUND: Polycystic ovary syndrome (PCOS) is related to metabolic syndrome, insulin resistance, and cardiovascular metabolic syndromes. This is particularly true for individuals with central and abdominal obesity because visceral abdominal adipose tissue (VAAT) and epicardial adipose tissue (EAT)...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636769/ https://www.ncbi.nlm.nih.gov/pubmed/26545735 http://dx.doi.org/10.1186/s13048-015-0197-4 |
_version_ | 1782399699568820224 |
---|---|
author | Arpaci, Dilek Gurkan Tocoglu, Aysel Yilmaz, Sabiye Ergenc, Hasan Tamer, Ali Keser, Nurgul Gunduz, Huseyin |
author_facet | Arpaci, Dilek Gurkan Tocoglu, Aysel Yilmaz, Sabiye Ergenc, Hasan Tamer, Ali Keser, Nurgul Gunduz, Huseyin |
author_sort | Arpaci, Dilek |
collection | PubMed |
description | BACKGROUND: Polycystic ovary syndrome (PCOS) is related to metabolic syndrome, insulin resistance, and cardiovascular metabolic syndromes. This is particularly true for individuals with central and abdominal obesity because visceral abdominal adipose tissue (VAAT) and epicardial adipose tissue (EAT) produce a large number of proinflammatory and proatherogenic cytokines. The present study aimed to determine whether there are changes in VAAT and EAT levels which were considered as indirect predictors for subclinical atherosclerosis in lean patients with PCOS. METHODS: The clinical and demographic characteristics of 35 patients with PCOS and 38 healthy control subjects were recorded for the present study. Additionally, the serum levels of various biochemical parameters were measured and EAT levels were assessed using 2D-transthoracic echocardiography. RESULTS: There were no significant differences in mean age (p = 0.056) or mean body mass index (BMI) (p = 0.446) between the patient and control groups. However, the body fat percentage, waist-to-hip ratio, amount of abdominal subcutaneous adipose tissue, and VAAT thickness were higher in the PCOS patient group than in the control group. The amounts of EAT in the patient and control groups were similar (p = 0.384). EAT was correlated with BMI, fat mass, waist circumference, and hip circumference but not with any biochemical metabolic parameters including the homeostasis model assessment of insulin resistance index or the levels of triglycerides, low-density lipoprotein cholesterol, and high-density lipoprotein (HDL) cholesterol. However, there was a small positive correlation between the amounts of VAAT and EAT. VAAT was directly correlated with body fat parameters such as BMI, fat mass, and abdominal subcutaneous adipose thickness and inversely correlated with the HDL cholesterol level. CONCLUSIONS: The present study found that increased abdominal adipose tissue in patients with PCOS was associated with atherosclerosis. Additionally, EAT may aid in the determination of the risk of atherosclerosis in patients with PCOS because it is easily measured. |
format | Online Article Text |
id | pubmed-4636769 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46367692015-11-08 The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome Arpaci, Dilek Gurkan Tocoglu, Aysel Yilmaz, Sabiye Ergenc, Hasan Tamer, Ali Keser, Nurgul Gunduz, Huseyin J Ovarian Res Research BACKGROUND: Polycystic ovary syndrome (PCOS) is related to metabolic syndrome, insulin resistance, and cardiovascular metabolic syndromes. This is particularly true for individuals with central and abdominal obesity because visceral abdominal adipose tissue (VAAT) and epicardial adipose tissue (EAT) produce a large number of proinflammatory and proatherogenic cytokines. The present study aimed to determine whether there are changes in VAAT and EAT levels which were considered as indirect predictors for subclinical atherosclerosis in lean patients with PCOS. METHODS: The clinical and demographic characteristics of 35 patients with PCOS and 38 healthy control subjects were recorded for the present study. Additionally, the serum levels of various biochemical parameters were measured and EAT levels were assessed using 2D-transthoracic echocardiography. RESULTS: There were no significant differences in mean age (p = 0.056) or mean body mass index (BMI) (p = 0.446) between the patient and control groups. However, the body fat percentage, waist-to-hip ratio, amount of abdominal subcutaneous adipose tissue, and VAAT thickness were higher in the PCOS patient group than in the control group. The amounts of EAT in the patient and control groups were similar (p = 0.384). EAT was correlated with BMI, fat mass, waist circumference, and hip circumference but not with any biochemical metabolic parameters including the homeostasis model assessment of insulin resistance index or the levels of triglycerides, low-density lipoprotein cholesterol, and high-density lipoprotein (HDL) cholesterol. However, there was a small positive correlation between the amounts of VAAT and EAT. VAAT was directly correlated with body fat parameters such as BMI, fat mass, and abdominal subcutaneous adipose thickness and inversely correlated with the HDL cholesterol level. CONCLUSIONS: The present study found that increased abdominal adipose tissue in patients with PCOS was associated with atherosclerosis. Additionally, EAT may aid in the determination of the risk of atherosclerosis in patients with PCOS because it is easily measured. BioMed Central 2015-11-06 /pmc/articles/PMC4636769/ /pubmed/26545735 http://dx.doi.org/10.1186/s13048-015-0197-4 Text en © Arpaci et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Arpaci, Dilek Gurkan Tocoglu, Aysel Yilmaz, Sabiye Ergenc, Hasan Tamer, Ali Keser, Nurgul Gunduz, Huseyin The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome |
title | The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome |
title_full | The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome |
title_fullStr | The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome |
title_full_unstemmed | The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome |
title_short | The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome |
title_sort | relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636769/ https://www.ncbi.nlm.nih.gov/pubmed/26545735 http://dx.doi.org/10.1186/s13048-015-0197-4 |
work_keys_str_mv | AT arpacidilek therelationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome AT gurkantocogluaysel therelationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome AT yilmazsabiye therelationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome AT ergenchasan therelationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome AT tamerali therelationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome AT kesernurgul therelationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome AT gunduzhuseyin therelationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome AT arpacidilek relationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome AT gurkantocogluaysel relationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome AT yilmazsabiye relationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome AT ergenchasan relationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome AT tamerali relationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome AT kesernurgul relationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome AT gunduzhuseyin relationshipbetweenepicardialfattissuethicknessandvisceraladiposetissueinleanpatientswithpolycysticovarysyndrome |